Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2021 Filed Sep 17, 2021 21:21 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 3,500 | $125.00 | $437,500.00 |
DisclosureSEC source: 0001438133-21-000176 · wf-form4_163191367972066.xml · nonDerivative · entry 2 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,145 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2021. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 21:21 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 3,500 | $18.86 | $66,010.00 |
DisclosureSEC source: 0001438133-21-000176 · wf-form4_163191367972066.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 21:18 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
Exercise / conversionStock Option · Derivative | 9,000 | $18.86 Strike: $18.86 | $169,740.00 |
DisclosureSEC source: 0001438133-21-000174 · wf-form4_163191347219012.xml · derivative · entry 6 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,000 Underlying: Common Stock · 9,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The options vested as to fifty percent (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter. F8 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 21:18 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
SaleCommon Stock | 4,300 | $122.64 | $527,333.08 |
DisclosureSEC source: 0001438133-21-000174 · wf-form4_163191347219012.xml · nonDerivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,247 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $122.20 to $122.77. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 21:18 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
SaleCommon Stock | 3,068 | $121.66 | $373,262.39 |
DisclosureSEC source: 0001438133-21-000174 · wf-form4_163191347219012.xml · nonDerivative · entry 3 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,547 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $121.19 to $122.16. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 21:18 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
SaleCommon Stock | 1,632 | $120.93 | $197,359.23 |
DisclosureSEC source: 0001438133-21-000174 · wf-form4_163191347219012.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,615 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $120.19 to $121.17. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 21:18 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
Exercise / conversionCommon Stock | 9,000 | $18.86 | $169,740.00 |
DisclosureSEC source: 0001438133-21-000174 · wf-form4_163191347219012.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 21:01 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Exercise / conversionStock Option · Derivative | 10,000 | $18.86 Strike: $18.86 | $188,600.00 |
DisclosureSEC source: 0001438133-21-000167 · wf-form4_163173969013981.xml · derivative · entry 6 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,160 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 6/14/2019, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F8 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 21:01 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 2,000 | $122.39 | $244,780.00 |
DisclosureSEC source: 0001438133-21-000167 · wf-form4_163173969013981.xml · nonDerivative · entry 4 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,145 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2021. F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $122.04 to $122.71. The Reporting Person undertakes to provide the Securitiesand Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 21:01 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,300 | $121.38 | $157,794.00 |
DisclosureSEC source: 0001438133-21-000167 · wf-form4_163173969013981.xml · nonDerivative · entry 3 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,145 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2021. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $121.01 to $121.95. The Reporting Person undertakes to provide the Securitiesand Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 21:01 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 6,700 | $120.14 | $804,938.00 |
DisclosureSEC source: 0001438133-21-000167 · wf-form4_163173969013981.xml · nonDerivative · entry 2 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,445 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2021. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $120.00 to $120.67. The Reporting Person undertakes to provide the Securitiesand Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 21:01 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 10,000 | $18.86 | $188,600.00 |
DisclosureSEC source: 0001438133-21-000167 · wf-form4_163173969013981.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 20:32 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Exercise / conversionStock Option · Derivative | 30,000 | $51.50 Strike: $51.50 | $1,545,000.00 |
DisclosureSEC source: 0001438133-21-000165 · wf-form4_163173794853662.xml · derivative · entry 9 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to (the "2013 Plan"). F9 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 20:32 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Exercise / conversionStock Option · Derivative | 2,180 | $9.00 Strike: $9.00 | $19,620.00 |
DisclosureSEC source: 0001438133-21-000165 · wf-form4_163173794853662.xml · derivative · entry 8 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,180 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 5/17/2018, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F9 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 20:32 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 1,300 | $122.44 | $159,172.00 |
DisclosureSEC source: 0001438133-21-000165 · wf-form4_163173794853662.xml · nonDerivative · entry 7 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,333 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2021. F7 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $122.03 to $122.99. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 20:32 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 1,900 | $121.68 | $231,192.00 |
DisclosureSEC source: 0001438133-21-000165 · wf-form4_163173794853662.xml · nonDerivative · entry 6 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,633 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2021. F6 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $121.01 to $121.98. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 20:32 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 2,180 | $120.33 | $262,319.40 |
DisclosureSEC source: 0001438133-21-000165 · wf-form4_163173794853662.xml · nonDerivative · entry 5 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,533 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2021. F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $119.76 to $120.67. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 20:32 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 11,800 | $119.03 | $1,404,554.00 |
DisclosureSEC source: 0001438133-21-000165 · wf-form4_163173794853662.xml · nonDerivative · entry 4 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,713 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2021. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $118.64 to $119.61. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 20:32 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 15,000 | $118.14 | $1,772,100.00 |
DisclosureSEC source: 0001438133-21-000165 · wf-form4_163173794853662.xml · nonDerivative · entry 3 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,513 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2021. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $117.64 to $118.60. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 20:32 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 30,000 | $51.50 | $1,545,000.00 |
DisclosureSEC source: 0001438133-21-000165 · wf-form4_163173794853662.xml · nonDerivative · entry 2 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 20:32 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 2,180 | $9.00 | $19,620.00 |
DisclosureSEC source: 0001438133-21-000165 · wf-form4_163173794853662.xml · nonDerivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 20:31 UTC |
TWOMEY CHRISTOPHER JDirector
|
GiftCommon Stock | 2,500 | $129.09 | $322,712.50 |
DisclosureSEC source: 0001438133-21-000161 · wf-form4_163121946475437.xml · nonDerivative · entry 2 TWOMEY CHRISTOPHER J · CIK 0001238935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,032 F3 · kind: The shares were given as a bona fide gift to the Chris and Rebecca Twomey Family Foundation at the San Diego Foundation. F4 · price: The price per share reflects the average of the high and low trading prices of the Company's stock on the transaction date. F2 · ownership.nature: The securities are held by the Chris J. Twomey and Rebecca J. Twomey Family Trust UTD September 20, 2002. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 16:38 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionStock Option · Derivative | 3,574 | $82.34 Strike: $82.34 | $294,283.16 |
DisclosureSEC source: 0001438133-21-000163 · wf-form4_163121987607887.xml · derivative · entry 3 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,862 Underlying: Common Stock · 3,574 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 16:38 UTC |
Leal JamesSVP, Operations
|
SaleCommon Stock | 3,574 | $123.00 | $439,602.00 |
DisclosureSEC source: 0001438133-21-000163 · wf-form4_163121987607887.xml · nonDerivative · entry 2 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,751 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 16:38 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionCommon Stock | 3,574 | $82.34 | $294,283.16 |
DisclosureSEC source: 0001438133-21-000163 · wf-form4_163121987607887.xml · nonDerivative · entry 1 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 20:31 UTC |
TWOMEY CHRISTOPHER JDirector
|
SaleCommon Stock | 304 | $123.00 | $37,392.00 |
DisclosureSEC source: 0001438133-21-000161 · wf-form4_163121946475437.xml · nonDerivative · entry 1 TWOMEY CHRISTOPHER J · CIK 0001238935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 7,532 F1 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2021. F2 · ownership.nature: The securities are held by the Chris J. Twomey and Rebecca J. Twomey Family Trust UTD September 20, 2002. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 22:38 UTC |
TWOMEY CHRISTOPHER JDirector
|
SaleCommon Stock | 4,696 | $115.01 | $540,077.10 |
DisclosureSEC source: 0001438133-21-000159 · wf-form4_163070867372263.xml · nonDerivative · entry 2 TWOMEY CHRISTOPHER J · CIK 0001238935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 7,836 F1 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2021. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $115.00 to $115.21. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. F5 · ownership.nature: The securities are held by the Chris J. Twomey and Rebecca J. Twomey Family Trust UTD September 20, 2002. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 22:38 UTC |
TWOMEY CHRISTOPHER JDirector
|
SaleCommon Stock | 4,000 | $115.00 | $460,000.40 |
DisclosureSEC source: 0001438133-21-000159 · wf-form4_163070867372263.xml · nonDerivative · entry 1 TWOMEY CHRISTOPHER J · CIK 0001238935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 7,523 F1 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2021. F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $115.00 to $115.12. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. F3 · ownership.nature: The securities are directly owed by Twomey Family Investments, LLC. The Reporting Person is co-manager of Twomey Family Investments, LLC and shares voting and investment power over the securities held by Twomey Family Investments, LLC and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Twomey Family Investments, LLC, except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 21:08 UTC |
BLICKENSTAFF KIM DDirector
|
SaleCommon Stock | 300 | $114.26 | $34,278.00 |
DisclosureSEC source: 0001438133-21-000157 · wf-form4_163070329897998.xml · nonDerivative · entry 2 BLICKENSTAFF KIM D · CIK 0001238913 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 202,390 F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $114.25 to $114.26. The Reporting Person undertakes to provide the Securitiesand Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. F2 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 21:08 UTC |
BLICKENSTAFF KIM DDirector
|
SaleCommon Stock | 28,400 | $113.35 | $3,219,140.00 |
DisclosureSEC source: 0001438133-21-000157 · wf-form4_163070329897998.xml · nonDerivative · entry 1 BLICKENSTAFF KIM D · CIK 0001238913 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 202,690 F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $113.25 to $113.78. The Reporting Person undertakes to provide the Securitiesand Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. F2 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 16:38 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionStock Option · Derivative | 1,667 | $51.50 Strike: $51.50 | $85,850.50 |
DisclosureSEC source: 0001438133-21-000151 · wf-form4_163044226973410.xml · derivative · entry 7 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 1,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F9 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 16:38 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionRestricted Stock Unit · Derivative | 309 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000151 · wf-form4_163044226973410.xml · derivative · entry 6 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,407 Underlying: Common Stock · 309 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F7 · derivative.exercise_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F7 · derivative.expiration_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 16:38 UTC |
Leal JamesSVP, Operations
|
SaleCommon Stock | 167 | $111.12 | $18,557.04 |
DisclosureSEC source: 0001438133-21-000151 · wf-form4_163044226973410.xml · nonDerivative · entry 5 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,751 F3 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 16:38 UTC |
Leal JamesSVP, Operations
|
SaleCommon Stock | 1,500 | $110.59 | $165,885.00 |
DisclosureSEC source: 0001438133-21-000151 · wf-form4_163044226973410.xml · nonDerivative · entry 4 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,918 F3 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $110.00 to $110.98. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 16:38 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionCommon Stock | 1,667 | $51.50 | $85,850.50 |
DisclosureSEC source: 0001438133-21-000151 · wf-form4_163044226973410.xml · nonDerivative · entry 3 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 16:38 UTC |
Leal JamesSVP, Operations
|
Tax withholdingCommon Stock | 154 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000151 · wf-form4_163044226973410.xml · nonDerivative · entry 2 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,751 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 16:38 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionCommon Stock | 309 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000151 · wf-form4_163044226973410.xml · nonDerivative · entry 1 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,905 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:34 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 372 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000149 · wf-form4_163044205077949.xml · derivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,099 Underlying: Common Stock · 372 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F4 · derivative.exercise_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:34 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Tax withholdingCommon Stock | 129 | $110.31 | $14,229.99 |
DisclosureSEC source: 0001438133-21-000149 · wf-form4_163044205077949.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,218 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:34 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionCommon Stock | 372 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000149 · wf-form4_163044205077949.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:25 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000143 · wf-form4_163044152907433.xml · derivative · entry 4 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,471 Underlying: Common Stock · 407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F4 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Tandem common stock. F5 · derivative.exercise_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F5 · derivative.expiration_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:25 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 141 | $110.31 | $15,553.71 |
DisclosureSEC source: 0001438133-21-000143 · wf-form4_163044152907433.xml · nonDerivative · entry 2 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,145 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:25 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000143 · wf-form4_163044152907433.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:46 UTC |
BLICKENSTAFF KIM DDirector
|
Exercise / conversionSeries A Warrants · Derivative | 28,700 | $3.50 Strike: $3.50 | $100,450.00 |
DisclosureSEC source: 0001438133-21-000155 · wf-form4_163044280063824.xml · derivative · entry 3 BLICKENSTAFF KIM D · CIK 0001238913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,700 shares Expires 2022-10-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:46 UTC |
BLICKENSTAFF KIM DDirector
|
Exercise / conversionCommon Stock | 28,700 | $3.50 | $100,450.00 |
DisclosureSEC source: 0001438133-21-000155 · wf-form4_163044280063824.xml · nonDerivative · entry 1 BLICKENSTAFF KIM D · CIK 0001238913 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 231,090 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reflects the cash exercise of warrants to purchase common stock, at an exercise price of $3.50. F2 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:31 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 820 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000147 · wf-form4_163044189038301.xml · derivative · entry 3 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,017 Underlying: Common Stock · 820 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F4 · derivative.exercise_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:31 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 407 | $110.31 | $44,896.17 |
DisclosureSEC source: 0001438133-21-000147 · wf-form4_163044189038301.xml · nonDerivative · entry 2 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,610 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:31 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionCommon Stock | 820 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000147 · wf-form4_163044189038301.xml · nonDerivative · entry 1 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:42 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000153 · wf-form4_163044255983709.xml · derivative · entry 3 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,471 Underlying: Common Stock · 407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Tandem common stock. F4 · derivative.exercise_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:42 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Tax withholdingCommon Stock | 133 | $110.31 | $14,671.23 |
DisclosureSEC source: 0001438133-21-000153 · wf-form4_163044255983709.xml · nonDerivative · entry 2 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,333 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.